Hepatocellular carcinoma (HCC) is a morbid condition for which surgical and ablative
therapy are the only options for cure. Nonetheless, over half of patients treated with an R0 …

Background. Currently, no surveillance guidelines for hepatocellular carcinoma (HCC)
recurrence after liver transplantation (LT) exist. In this retrospective, multicenter study, we …

Hepatocellular carcinoma represents the most frequent primary liver tumor; curative options
are only surgical resection and liver transplantation. From 1996, Milan Criteria are applied in …

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortality
worldwide. The Brazilian Society of Hepatology (SBH) published in 2015 its first …

A surface-enhanced Raman scattering (SERS)-based sandwich type immunoassay was
developed for the detection of α-fetoprotein (AFP) with high sensitivity, reproducibility and …

Background: For individuals with hepatocellular carcinoma (HCC), type of insurance may be
an important prognostic factor because of its impact on access to care. This study …

Organ shortage requires policies and guidelines to aid organ allocation along the principles
of urgency or utility. Identifying patients with significant benefit and withholding liver …

Background High recurrence incidence and poor survival after hepatectomy are enormous
threats to hepatocellular carcinoma (HCC) patients, which can be caused by microvascular …

Cellular senescence is a fundamental cell fate caused by several cellular injuries which
results in irreversible cell cycle arrest yet remaining metabolically active across all species …

Background: Hepatocellular carcinoma (HCC) has high morbidity and mortality, but current
therapeutic methods cannot effectively improve patient's prognosis. FOXD3-AS1, a new …